Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) causes headaches in some people primarily because of mild dehydration and reduced calorie intake in the early weeks of treatment — both common side effects as your body adjusts. The NHS tirzepatide medicines page lists headache among the known side effects of tirzepatide, and it tends to be most noticeable around dose increases or when nausea leads to less eating and drinking than usual. For most people it settles within a few days to a couple of weeks. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your full picture before any treatment starts, and that includes discussing what to expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In the SURMOUNT-1 trial (a 72-week study of tirzepatide in adults living with obesity, published in the New England Journal of Medicine) the most commonly reported side effects were gastrointestinal: nausea, vomiting, diarrhoea and constipation. Headache appeared within the broader adverse-event profile rather than as a dominant signal, which tells us something useful: it is real and recognised, but it sits downstream of the GI effects rather than being a direct pharmacological action of tirzepatide itself.
The mechanism matters here. Tirzepatide activates both GLP-1 and GIP receptors, slowing how quickly food moves out of the stomach and significantly reducing appetite. When eating drops sharply, two things follow: fluid intake often falls with it, and blood glucose can dip relative to what the body is used to. Both are established triggers for tension-type headache in healthy adults. The NHS tirzepatide page lists headache as a common side effect (affecting up to 1 in 10 people) precisely because this pattern is consistent across the treatment population.
Timing is the clearest clue. If headaches cluster in the first few days after your pen day, or in the week following a dose increase, the cause is almost certainly adjustment rather than anything more serious. If you are wondering whether Mounjaro gives you headaches and why the timing follows this pattern, that pattern is well documented and, for most people, self-limiting. More about what headaches on Mounjaro typically feel like and how long they last is covered in a dedicated section of our clinical content.
Nausea is the side effect that most often tips people into mild dehydration on tirzepatide, because when your stomach feels unsettled, drinking feels harder. A slightly dehydrated brain sits in a skull with fractionally less fluid cushioning it: that is a textbook tension headache waiting to happen. The fix is genuinely simple in principle, small, frequent sips of water throughout the day, rather than trying to drink a large glass all at once when you already feel queasy.
Some people keep a small bottle in the pocket of their gym bag as a prompt; others tie it to an existing habit, like a glass of water before the kettle goes on for a morning coffee. The method matters less than consistency. Electrolytes (a pinch of salt in water, or a low-sugar electrolyte drink) can help if nausea has been prolonged, though your prescriber is the right person to advise on anything beyond plain hydration.
Reduced calorie intake plays a separate role. Tirzepatide suppresses appetite meaningfully, and if meals become very small or widely spaced, blood-sugar fluctuations can follow. Prioritising protein and eating at regular intervals (even if portions are much smaller than before) tends to smooth this out. For a fuller picture of Mounjaro's side effects and how people manage them, our clinical team has put together a detailed overview.
Caffeine withdrawal is worth a brief mention too. If nausea puts you off your usual morning coffee, a caffeine-withdrawal headache can layer on top of everything else. Tapering slowly, or switching to smaller amounts, helps more than going cold turkey.
Most Mounjaro headaches are a nuisance, not a warning. The ones that need prompt attention are different in character: sudden, severe or described as the worst headache of your life; headache accompanied by visual changes, one-sided weakness or difficulty speaking; or (critically) headache that comes alongside severe, persistent stomach pain that radiates towards the back.
That last combination matters because the MHRA's Drug Safety Update on GLP-1 medicines (January 2026) highlighted acute pancreatitis as an infrequent but serious side effect: severe abdominal pain, sometimes with vomiting, that persists and can spread to the back. Pancreatitis is not common, but it is the kind of thing that should not be waited out at home. If that pattern describes what you are experiencing, seek urgent medical assessment.
For side effects that are bothersome but not urgent (headaches that keep returning, or that feel more intrusive than you expected) our prescribers talk this through as part of every review. You can also report any suspected side effect directly to the MHRA using the Yellow Card scheme. That data helps regulators track patterns across the whole treatment population, so reporting genuinely matters. If you have questions about whether what you are experiencing is typical, our team is available seven days a week.
Headaches that flare specifically around dose increases follow a predictable logic: tirzepatide is titrated through a schedule starting at 2.5 mg, with each step upward repeating a milder version of the early-treatment adjustment. The body tends to adapt at each new level, so the headaches are often shorter-lived with each successive increase. If you are still unsure whether Mounjaro can cause headaches and what drives them at each stage of titration, that is clinical information your prescriber needs.
Timing your dose consistently, staying ahead of hydration (especially on the day of injection and the two days after), and keeping a simple note of when headaches occur and how long they last gives your prescriber useful data to work with. It is the kind of detail that helps distinguish adjustment from something that needs a different approach, and it makes the conversation at your next review much more productive. More on the relationship between Mounjaro dose timing and headache is explored in our prescribers' clinical notes.
Mounjaro is available through a free consultation with our GPhC-registered prescribers, they cover expected side effects, how to manage them, and how to reach us if something changes. If you are weighing up the cost of Mounjaro through different providers, our clinician-led service includes prescriber aftercare seven days a week as part of one transparent price.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.